Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.

PHASE4CompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Type 2 Diabetes
Interventions
DRUG

Bydureon

Once weekly injection of 2mg bydureon (extended release exenatide) for 10 weeks.

DRUG

Placebo

Placebo

Trial Locations (29)

Unknown

Research Site, Anaheim

Research Site, Chino

Research Site, Los Angeles

Research Site, North Hollywood

Research Site, Santa Ana

Research Site, Spring Valley

Research Site, Tustin

Research Site, Walnut Creek

Research Site, Hollywood

Research Site, Miami

Research Site, Port Orange

Research Site, Marietta

Research Site, Chicago

Research Site, Edina

Research Site, St Louis

Research Site, Butte

Research Site, Las Vegas

Research Site, Franklin

Research Site, Marion

Research Site, Oklahoma City

Research Site, Mt. Pleasant

Research Site, Rapid City

Research Site, Corpus Christi

Research Site, Houston

Research Site, Katy

Research Site, Salt Lake City

Research Site, Burke

Research Site, Manassas

Research Site, Olympia

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY